Wellbeing Magazine on MSN
Optimizing sample throughput in large-scale NGS sequencing services
As demand for high-throughput genomic profiling continues to grow, laboratories and research organizations face increasing pressure to maximize sample throughput The post Optimizing Sample Throughput ...
Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, today announced that Basecamp Research, a frontier AI lab for therapeutic design, has selected the UG200 Series as the ...
VITARI will begin shipping in the second half of 2026, with pre-orders now open and early customer commitments already secured SAN DIEGO--(BUSINESS WIRE)--Element Biosciences Inc. today announced ...
Normalization by Ligationâ„¢ library preparation technology processes thousands of samples at low cost with enhanced multiplexing and novel streamlined workflow SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...
In this webinar, Stefan Radtke will discuss the development of new high-throughput single-cell readouts for precise and comprehensive tracking of gene editing outcomes after autologous hematopoietic ...
Despite modern high-throughput sequencing, the genetic cause of most rare movement disorders remains unclear. A research team ...
Pioneering research utilizes high-throughput single-cell sequencing to demystify the microbial universe within activated sludge, a cornerstone of wastewater treatment. This study has unearthed a ...
MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
Despite modern high-throughput sequencing, the genetic cause of most rare movement disorders remains unclear. A research team in Bochum and Tübingen has now solved one piece of the puzzle: The ...
DNA sequencing technology has become a laboratory staple, helping scientists advance genomics research by leaps and bounds. However, analyzing vast amounts of genetic material often leads to ...
The global DNA sequencing market is projected to reach USD 40.02 billion by 2031, driven by declining sequencing costs, expanding clinical applications in oncology and rare diseases, and growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results